Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade

Objective Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated pro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 2019-04, Vol.83 (4), p.625-637
Hauptverfasser: Jia, Qiu-ping, Yan, Chang-you, Zheng, Xue-rong, Pan, Xia, Cao, Xin, Cao, Lei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 637
container_issue 4
container_start_page 625
container_title Cancer chemotherapy and pharmacology
container_volume 83
creator Jia, Qiu-ping
Yan, Chang-you
Zheng, Xue-rong
Pan, Xia
Cao, Xin
Cao, Lei
description Objective Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells. Methods MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels. Results Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the APOBEC3B promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment. Conclusions These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa.
doi_str_mv 10.1007/s00280-018-03766-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2165962905</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2165962905</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</originalsourceid><addsrcrecordid>eNp9kUtOHDEURa0oUegAG2CALGXs8Pwpl2vY3UASiQADGFsu1ysoVD_srlZYTDaSRWRNcdP8RowsP597r54vIQccvnGA_CgCCAMMuGEgc62Z-EBmXEnBwCj5kcxAKsWyHNQO-RLjHQAoLuVnsiNBS24KMyN_rseAN1PrVs3Q06Gmv67mnOLvNI1xMyof6O3UuZ6ObmzadujcuglTpE1fo38UjWHohhVGujw-vqRJ18SV6z0mhHoM68a7lvrNJKR720a6bhzthupN6vkp-_d3cTS_vFicLOUi4dG7CvfIp9q1Efefzl1yfXpytfzBzi6-_1zOz5gXBQgmpSwqRF1UZYF5XelMudJxU2shvUFfAgqZc48GdF0JU9aGi9yVmU_fqJSSu-Tr1jftcj9hXNm7YQp9irSC66zQKSZLlNhSPgwxBqztGJrOhQfLwW4asdtGbGrEPjZiRRIdPllPZYfVi-S5ggTILRDTU3-D4TX7Hdv_r1OYaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2165962905</pqid></control><display><type>article</type><title>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Jia, Qiu-ping ; Yan, Chang-you ; Zheng, Xue-rong ; Pan, Xia ; Cao, Xin ; Cao, Lei</creator><creatorcontrib>Jia, Qiu-ping ; Yan, Chang-you ; Zheng, Xue-rong ; Pan, Xia ; Cao, Xin ; Cao, Lei</creatorcontrib><description>Objective Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells. Methods MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels. Results Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the APOBEC3B promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment. Conclusions These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa.</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/s00280-018-03766-2</identifier><identifier>PMID: 30631898</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Apoptosis ; Cancer ; Cancer Research ; Carcinogenesis ; Carcinogens ; Cervical cancer ; Cervix ; Chemoresistance ; Chemotherapy ; Chromatin ; Cisplatin ; Cisplatin - pharmacology ; Cytidine Deaminase - metabolism ; Cytosine ; Cytosine deaminase ; Deoxyribonucleic acid ; Deregulation ; DNA ; DNA-Binding Proteins - metabolism ; Etiology ; Female ; Gene regulation ; Human papillomavirus ; Humans ; Immunoblotting ; Immunoprecipitation ; In vivo methods and tests ; Lesions ; Medicine ; Medicine &amp; Public Health ; Metastases ; Metastasis ; Mice, Inbred BALB C ; Mice, Nude ; Minor Histocompatibility Antigens - metabolism ; Mutagenesis ; NF-kappa B - metabolism ; NF-κB protein ; Oncogene Proteins, Viral - metabolism ; Oncology ; Original Article ; Papillomaviridae ; Papillomavirus Infections - complications ; Pathogenesis ; Pharmacology/Toxicology ; Polymerase chain reaction ; Proteins ; Repressor Proteins - genetics ; siRNA ; Trans-Activators - genetics ; Transcription ; Transfection ; Up-Regulation ; Uterine Cervical Neoplasms - drug therapy ; Uterine Cervical Neoplasms - virology ; Xenograft Model Antitumor Assays</subject><ispartof>Cancer chemotherapy and pharmacology, 2019-04, Vol.83 (4), p.625-637</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2019</rights><rights>Cancer Chemotherapy and Pharmacology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</citedby><cites>FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00280-018-03766-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00280-018-03766-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30631898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jia, Qiu-ping</creatorcontrib><creatorcontrib>Yan, Chang-you</creatorcontrib><creatorcontrib>Zheng, Xue-rong</creatorcontrib><creatorcontrib>Pan, Xia</creatorcontrib><creatorcontrib>Cao, Xin</creatorcontrib><creatorcontrib>Cao, Lei</creatorcontrib><title>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><addtitle>Cancer Chemother Pharmacol</addtitle><description>Objective Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells. Methods MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels. Results Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the APOBEC3B promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment. Conclusions These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Cancer</subject><subject>Cancer Research</subject><subject>Carcinogenesis</subject><subject>Carcinogens</subject><subject>Cervical cancer</subject><subject>Cervix</subject><subject>Chemoresistance</subject><subject>Chemotherapy</subject><subject>Chromatin</subject><subject>Cisplatin</subject><subject>Cisplatin - pharmacology</subject><subject>Cytidine Deaminase - metabolism</subject><subject>Cytosine</subject><subject>Cytosine deaminase</subject><subject>Deoxyribonucleic acid</subject><subject>Deregulation</subject><subject>DNA</subject><subject>DNA-Binding Proteins - metabolism</subject><subject>Etiology</subject><subject>Female</subject><subject>Gene regulation</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Immunoprecipitation</subject><subject>In vivo methods and tests</subject><subject>Lesions</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Nude</subject><subject>Minor Histocompatibility Antigens - metabolism</subject><subject>Mutagenesis</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB protein</subject><subject>Oncogene Proteins, Viral - metabolism</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Papillomaviridae</subject><subject>Papillomavirus Infections - complications</subject><subject>Pathogenesis</subject><subject>Pharmacology/Toxicology</subject><subject>Polymerase chain reaction</subject><subject>Proteins</subject><subject>Repressor Proteins - genetics</subject><subject>siRNA</subject><subject>Trans-Activators - genetics</subject><subject>Transcription</subject><subject>Transfection</subject><subject>Up-Regulation</subject><subject>Uterine Cervical Neoplasms - drug therapy</subject><subject>Uterine Cervical Neoplasms - virology</subject><subject>Xenograft Model Antitumor Assays</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kUtOHDEURa0oUegAG2CALGXs8Pwpl2vY3UASiQADGFsu1ysoVD_srlZYTDaSRWRNcdP8RowsP597r54vIQccvnGA_CgCCAMMuGEgc62Z-EBmXEnBwCj5kcxAKsWyHNQO-RLjHQAoLuVnsiNBS24KMyN_rseAN1PrVs3Q06Gmv67mnOLvNI1xMyof6O3UuZ6ObmzadujcuglTpE1fo38UjWHohhVGujw-vqRJ18SV6z0mhHoM68a7lvrNJKR720a6bhzthupN6vkp-_d3cTS_vFicLOUi4dG7CvfIp9q1Efefzl1yfXpytfzBzi6-_1zOz5gXBQgmpSwqRF1UZYF5XelMudJxU2shvUFfAgqZc48GdF0JU9aGi9yVmU_fqJSSu-Tr1jftcj9hXNm7YQp9irSC66zQKSZLlNhSPgwxBqztGJrOhQfLwW4asdtGbGrEPjZiRRIdPllPZYfVi-S5ggTILRDTU3-D4TX7Hdv_r1OYaA</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Jia, Qiu-ping</creator><creator>Yan, Chang-you</creator><creator>Zheng, Xue-rong</creator><creator>Pan, Xia</creator><creator>Cao, Xin</creator><creator>Cao, Lei</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>201904</creationdate><title>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</title><author>Jia, Qiu-ping ; Yan, Chang-you ; Zheng, Xue-rong ; Pan, Xia ; Cao, Xin ; Cao, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2902-3339dee69db9e7fd654aba18f623c8ecb0e2371ce806fd28bf8127ab5c0074443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Cancer</topic><topic>Cancer Research</topic><topic>Carcinogenesis</topic><topic>Carcinogens</topic><topic>Cervical cancer</topic><topic>Cervix</topic><topic>Chemoresistance</topic><topic>Chemotherapy</topic><topic>Chromatin</topic><topic>Cisplatin</topic><topic>Cisplatin - pharmacology</topic><topic>Cytidine Deaminase - metabolism</topic><topic>Cytosine</topic><topic>Cytosine deaminase</topic><topic>Deoxyribonucleic acid</topic><topic>Deregulation</topic><topic>DNA</topic><topic>DNA-Binding Proteins - metabolism</topic><topic>Etiology</topic><topic>Female</topic><topic>Gene regulation</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Immunoprecipitation</topic><topic>In vivo methods and tests</topic><topic>Lesions</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Nude</topic><topic>Minor Histocompatibility Antigens - metabolism</topic><topic>Mutagenesis</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB protein</topic><topic>Oncogene Proteins, Viral - metabolism</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Papillomaviridae</topic><topic>Papillomavirus Infections - complications</topic><topic>Pathogenesis</topic><topic>Pharmacology/Toxicology</topic><topic>Polymerase chain reaction</topic><topic>Proteins</topic><topic>Repressor Proteins - genetics</topic><topic>siRNA</topic><topic>Trans-Activators - genetics</topic><topic>Transcription</topic><topic>Transfection</topic><topic>Up-Regulation</topic><topic>Uterine Cervical Neoplasms - drug therapy</topic><topic>Uterine Cervical Neoplasms - virology</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jia, Qiu-ping</creatorcontrib><creatorcontrib>Yan, Chang-you</creatorcontrib><creatorcontrib>Zheng, Xue-rong</creatorcontrib><creatorcontrib>Pan, Xia</creatorcontrib><creatorcontrib>Cao, Xin</creatorcontrib><creatorcontrib>Cao, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jia, Qiu-ping</au><au>Yan, Chang-you</au><au>Zheng, Xue-rong</au><au>Pan, Xia</au><au>Cao, Xin</au><au>Cao, Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><stitle>Cancer Chemother Pharmacol</stitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>2019-04</date><risdate>2019</risdate><volume>83</volume><issue>4</issue><spage>625</spage><epage>637</epage><pages>625-637</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><abstract>Objective Compelling evidence establishes the etiological role of viral proteins E6 and E7 of high-risk human papillomaviruses (HPV) in cervical carcinogenesis, but their contribution in chemoresistance that leads to advanced metastatic lesions remains poorly defined. Since metastasis-associated protein 1 (MTA1) upregulation and augmentation of APOBEC3B expression are both strongly associated with cervical cancer (CCa) development, and both molecules have been shown to be functionally associated with NF-κB pathway, we therefore sought to investigate the potential mechanistic link between MTA1, APOBEC3B and NF-κB during the pathogenesis of cisplatin (CDDP) resistance in HPV-positive CCa cells. Methods MTA1 expression was assessed in HPV-transfected CCa cells using quantitative RT-PCR and immunoblotting. Effects of MTA1 deregulation on CDDP chemosensitivity in CCa cells were determined by measuring cell viability, apoptosis and in vivo oncogenic capacity. Finally, we studied the transcriptional regulation of the antiviral DNA cytosine deaminase APOBEC3B by MTA1 using multiple approaches including DNA deaminase activity assay, luciferase reporter assay, chromatin immunoprecipitation, co-immunoprecipitation and transient/stable transfection, at the molecular and functional levels. Results Expression levels of MTA1 were significantly induced in HPV-positive CCa cells. Transduction experiments showed that the E6 oncoprotein alone was sufficient to cause MTA1 upregulation. Moreover, MTA1 knockdown potentiated CDDP sensitivity in highly metastatic CCa cells. Mechanistically, MTA1 acted as an indirect upstream modulator of APOBEC3B transcription during the pathogenesis of CDDP chemoresistance. HPV-mediated stimulation of APOBEC3B expression was accompanied by the enhanced recruitment of Iκκ α/β and p65 to the NF-κB consensus sites in the APOBEC3B promoter, and this recruitment was substantially abrogated by MTA1 siRNA treatment. Conclusions These findings reveal an obligatory coregulatory role of MTA1 in the indirect regulation of APOBEC3B expression via classical NF-κB pathway, and also suggest that inhibition of MTA1/NF-κB/APOBEC3B cascade may be repositioned to suppress cancer mutagenesis, dampen tumor evolution, and decrease the probability of adverse outcomes from CDDP resistance in CCa.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30631898</pmid><doi>10.1007/s00280-018-03766-2</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0344-5704
ispartof Cancer chemotherapy and pharmacology, 2019-04, Vol.83 (4), p.625-637
issn 0344-5704
1432-0843
language eng
recordid cdi_proquest_journals_2165962905
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Animals
Antineoplastic Agents - pharmacology
Apoptosis
Cancer
Cancer Research
Carcinogenesis
Carcinogens
Cervical cancer
Cervix
Chemoresistance
Chemotherapy
Chromatin
Cisplatin
Cisplatin - pharmacology
Cytidine Deaminase - metabolism
Cytosine
Cytosine deaminase
Deoxyribonucleic acid
Deregulation
DNA
DNA-Binding Proteins - metabolism
Etiology
Female
Gene regulation
Human papillomavirus
Humans
Immunoblotting
Immunoprecipitation
In vivo methods and tests
Lesions
Medicine
Medicine & Public Health
Metastases
Metastasis
Mice, Inbred BALB C
Mice, Nude
Minor Histocompatibility Antigens - metabolism
Mutagenesis
NF-kappa B - metabolism
NF-κB protein
Oncogene Proteins, Viral - metabolism
Oncology
Original Article
Papillomaviridae
Papillomavirus Infections - complications
Pathogenesis
Pharmacology/Toxicology
Polymerase chain reaction
Proteins
Repressor Proteins - genetics
siRNA
Trans-Activators - genetics
Transcription
Transfection
Up-Regulation
Uterine Cervical Neoplasms - drug therapy
Uterine Cervical Neoplasms - virology
Xenograft Model Antitumor Assays
title Upregulation of MTA1 expression by human papillomavirus infection promotes CDDP resistance in cervical cancer cells via modulation of NF-κB/APOBEC3B cascade
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T00%3A37%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upregulation%20of%20MTA1%20expression%20by%20human%20papillomavirus%20infection%20promotes%20CDDP%20resistance%20in%20cervical%20cancer%20cells%20via%20modulation%20of%20NF-%CE%BAB/APOBEC3B%20cascade&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=Jia,%20Qiu-ping&rft.date=2019-04&rft.volume=83&rft.issue=4&rft.spage=625&rft.epage=637&rft.pages=625-637&rft.issn=0344-5704&rft.eissn=1432-0843&rft_id=info:doi/10.1007/s00280-018-03766-2&rft_dat=%3Cproquest_cross%3E2165962905%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2165962905&rft_id=info:pmid/30631898&rfr_iscdi=true